U.S. PHARMACOPEIA

Search USP29  
Metformin Hydrochloride Tablets
» Metformin Hydrochloride Tablets contain not less than 95.0 percent and not more than 105.0 percent of metformin hydrochloride (C4H11N5·HCl).
Packaging and storage— Preserve in tight containers. Store at controlled room temperature.
Labeling— When more than one Dissolution test is given, the labeling states the Dissolution test used only if Test 1 is not used.
Identification—
A: Infrared Absorption 197K.
Test specimen— Transfer a quantity of powdered Tablets, equivalent to about 20 mg of metformin hydrochloride, to a suitable flask, add 20 mL of dehydrated alcohol, and shake. Filter, evaporate the filtrate on a water bath to dryness, and dry the residue at 105 for 1 hour.
B: Triturate a quantity of the powdered Tablets, equivalent to about 50 mg of metformin hydrochloride, with 10 mL of water, and filter. To 5 mL of the filtrate add 1.5 mL of 5 N sodium hydroxide solution and 1 mL of a 1-naphthol solution, prepared by dissolving 1 g of 1-naphthol in a solution containing 6 g of sodium hydroxide and 16 g of anhydrous sodium carbonate in 100 mL of water. Add 0.5 mL of sodium hypochlorite TS, dropwise, and with shaking: an orange-red color is produced that darkens on standing.
C: Triturate a quantity of the powdered Tablets, equivalent to about 50 mg of metformin hydrochloride, with 10 mL of water, and filter. The filtrate meets the requirements of the tests for Chloride 191.
Dissolution 711
TEST 1—
Medium: pH 6.8 phosphate buffer; 1000 mL.
Apparatus 1: 100 rpm.
Time: 45 minutes.
Procedure— Determine the amount of C4H11N5·HCl dissolved by employing UV absorption at the wavelength of maximum absorbance at about 233 nm on filtered portions of the solution under test, suitably diluted with Medium, if necessary, in comparison with a Standard solution having a known concentration of USP Metformin Hydrochloride RS in the same Medium.
Tolerances— Not less than 70% (Q) of the labeled amount of C4H11N5·HCl is dissolved in 45 minutes.
TEST 2— If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 2.
For products labeled to contain 500 mg of metformin—
Medium: pH 6.8 phosphate buffer; 1000 mL.
Apparatus 2: 50 rpm.
Time: 30 minutes.
Procedure— Proceed as directed for Test 1.
Tolerances— Not less than 80% (Q) of the labeled amount of C4H11N5·HCl is dissolved in 30 minutes.
For products labeled to contain 850 mg or 1000 mg of metformin—
Medium: pH 6.8 phosphate buffer; 1000 mL.
Apparatus 2: 75 rpm.
Time: 30 minutes.
Procedure— Proceed as directed for Test 1.
Tolerances— Not less than 75% (Q) of the labeled amount of C4H11N5·HCl is dissolved in 30 minutes.
Uniformity of dosage units 905: meet the requirements.
Related compounds—
Mobile phase, Resolution solution, and Chromatographic system— Proceed as directed in the test for Related compounds under Metformin Hydrochloride.
Test solution— Weigh and finely powder not fewer than 20 Tablets. Transfer a portion of the powder, equivalent to about 500 mg of metformin hydrochloride, to a 100-mL volumetric flask, dissolve in Mobile phase, with shaking, dilute with Mobile phase to volume, and mix. Filter, and use the filtrate.
Diluted test solution— Proceed as directed for Metformin Hydrochloride, except to use the Test solution prepared as described herein.
Procedure— Separately inject equal volumes (about 20 µL) of the Test solution and the Diluted test solution into the chromatograph, record the chromatograms for not less than twice the retention time of metformin, and measure the peak areas.
The area of any secondary peak in the chromatogram of the Test solution is not greater than the area of the major peak in the chromatogram of the Diluted test solution; and the sum of the areas of all secondary peaks in the chromatogram of the Test solution is not greater than six times the area of the major peak in the chromatogram of the Diluted test solution: not more than 0.1% of any impurity is found; and not more than 0.6% of total impurities is found.
Residual solvents 467: meet the requirements.
(Official January 1, 2007)
Assay—
Standard preparation— Prepare a solution of USP Metformin Hydrochloride RS in water having a known concentration of about 10 µg per mL.
Assay preparation— Weigh and finely powder not fewer than 20 Tablets. Transfer an accurately weighed portion of the powder, equivalent to about 100 mg of metformin hydrochloride, to a 100-mL volumetric flask. Add 70 mL of water, shake by mechanical means for 15 minutes, dilute with water to volume, and filter, discarding the first 20 mL of the filtrate. Dilute 10.0 mL of the filtrate with water to 100.0 mL, and dilute 10.0 mL of the resulting solution with water to 100.0 mL.
Procedure— Concomitantly determine the absorbances of the Standard preparation and the Assay preparation, in 1-cm cells, at the wavelength of maximum absorbance at about 232 nm, with a suitable spectrophotometer, using water as a blank. Calculate the quantity, in mg, of metformin hydrochloride (C4H11N5·HCl) in the portion of Tablets taken by the formula:
10C(AU / AS),
in which C is the concentration, in µg per mL, of USP Metformin Hydrochloride RS in the Standard preparation; and AU and AS are the absorbances obtained from the Standard preparation and the Assay preparation, respectively.
Auxiliary Information— Staff Liaison : Elena Gonikberg, Ph.D., Scientist
Expert Committee : (MDGRE05) Monograph Development-Gastrointestinal Renal and Endocrine
USP29–NF24 Page 1365
Pharmacopeial Forum : Volume No. 31(4) Page 1093
Phone Number : 1-301-816-8251